Document
Genetic Testing Report (2.16.840.1.113883.10.20.20)
1. Header
  CDA recordTarget (2.16.840.1.113883.10.12.101)
  1. *
    CDA Person (2.16.840.1.113883.10.12.152)
  2. *
    CDA Organization (2.16.840.1.113883.10.12.151)
  3. *
    CDA Organization (2.16.840.1.113883.10.12.151)
2. Header
  CDA author (2.16.840.1.113883.10.12.102)
  1. *
    CDA Person (2.16.840.1.113883.10.12.152)
  2. Entry
    CDA Device (2.16.840.1.113883.10.12.315)
  3. *
    CDA Organization (2.16.840.1.113883.10.12.151)
3. Header
  CDA dataEnterer (2.16.840.1.113883.10.12.103)
  1. *
    CDA AssignedEntity (2.16.840.1.113883.10.12.153)
    1. *
      CDA Person (2.16.840.1.113883.10.12.152)
    2. *
      CDA Organization (2.16.840.1.113883.10.12.151)
4. Section
  CDA Informant (2.16.840.1.113883.10.12.154)
  1. *
    CDA AssignedEntity (2.16.840.1.113883.10.12.153)
    1. *
      CDA Person (2.16.840.1.113883.10.12.152)
    2. *
      CDA Organization (2.16.840.1.113883.10.12.151)
  2. Entry
    CDA RelatedEntity (2.16.840.1.113883.10.12.316)
    1. *
      CDA Person (2.16.840.1.113883.10.12.152)
5. Header
  CDA custodian (2.16.840.1.113883.10.12.104)
6. Header
  CDA informationRecipient (2.16.840.1.113883.10.12.105)
  1. *
    CDA Person (2.16.840.1.113883.10.12.152)
  2. *
    CDA Organization (2.16.840.1.113883.10.12.151)
7. Header
  CDA legalAuthenticator (2.16.840.1.113883.10.12.106)
  1. *
    CDA AssignedEntity (2.16.840.1.113883.10.12.153)
    1. *
      CDA Person (2.16.840.1.113883.10.12.152)
    2. *
      CDA Organization (2.16.840.1.113883.10.12.151)
8. Header
  CDA authenticator (2.16.840.1.113883.10.12.107)
  1. *
    CDA AssignedEntity (2.16.840.1.113883.10.12.153)
    1. *
      CDA Person (2.16.840.1.113883.10.12.152)
    2. *
      CDA Organization (2.16.840.1.113883.10.12.151)
9. Header
  CDA participant (2.16.840.1.113883.10.12.108)
  1. *
    CDA Person (2.16.840.1.113883.10.12.152)
  2. *
    CDA Organization (2.16.840.1.113883.10.12.151)
10. Header
  CDA inFulfillmentOf (2.16.840.1.113883.10.12.109)
11. Header
  CDA documentationOf (2.16.840.1.113883.10.12.110)
  1. *
    CDA AssignedEntity (2.16.840.1.113883.10.12.153)
    1. *
      CDA Person (2.16.840.1.113883.10.12.152)
    2. *
      CDA Organization (2.16.840.1.113883.10.12.151)
12. Header
  CDA relatedDocument (2.16.840.1.113883.10.12.111)
13. Header
  CDA Authorization (2.16.840.1.113883.10.12.114)
14. Header
  CDA componentOf (2.16.840.1.113883.10.12.113)
  1. *
    CDA AssignedEntity (2.16.840.1.113883.10.12.153)
    1. *
      CDA Person (2.16.840.1.113883.10.12.152)
    2. *
      CDA Organization (2.16.840.1.113883.10.12.151)
  2. *
    CDA AssignedEntity (2.16.840.1.113883.10.12.153)
    1. *
      CDA Person (2.16.840.1.113883.10.12.152)
    2. *
      CDA Organization (2.16.840.1.113883.10.12.151)
  3. Entry
    CDA Place (2.16.840.1.113883.10.12.317)
  4. *
    CDA Organization (2.16.840.1.113883.10.12.151)
15. Section
  Summary Section (2.16.840.1.113883.10.20.20.1.1)
  1. Section
    Indications Section (2.16.840.1.113883.10.20.20.1.11)
    1. Entry
      Indication Observation (2.16.840.1.113883.10.20.20.3.3)
    2. Entry
      Genetic Disease Assessed Indication Observation (2.16.840.1.113883.10.20.20.3.3.1)
    3. Entry
      Medication Assessed Indication Observation (2.16.840.1.113883.10.20.20.3.3.2)
  2. Section
    Summary Of Tests Performed Section (2.16.840.1.113883.10.20.20.1.1.6)
    1. Entry
      Test Performed Observation (2.16.840.1.113883.10.20.20.3.4)
  3. Section
    Overall Interpretation Section (2.16.840.1.113883.10.20.20.1.1.1)
    1. Entry
      Clinical Genomic Statement Overall Interpretation (2.16.840.1.113883.10.20.20.2.4)
      1. Entry
        Genomic Observations Organizer (2.16.840.1.113883.10.20.20.5.1)
        
        Entry
        Genomic Observation Reference (2.16.840.1.113883.10.20.20.6)
  4. Section
    Recommendations Section (2.16.840.1.113883.10.20.20.1.1.5)
  5. Section
    Specimen Section (2.16.840.1.113883.10.20.20.1.7)
    1. Entry
      Genomic Source Class (2.16.840.1.113883.10.20.20.3.2)
16. Section
  Test Details Section (2.16.840.1.113883.10.20.20.1.8)
  1. Entry
    Clinical Genomic Statement (2.16.840.1.113883.10.20.20.2)
    1. Entry
      Indication Observation (2.16.840.1.113883.10.20.20.3.3)
    2. Entry
      Interpretive Phenotype (2.16.840.1.113883.10.20.20.2.5)
    3. Entry
      Genomic Source Class (2.16.840.1.113883.10.20.20.3.2)
    4. Entry
      Genomic Associated Observation (2.16.840.1.113883.10.20.20.4)
  2. Section
    Indications Section (2.16.840.1.113883.10.20.20.1.11)
    1. Entry
      Indication Observation (2.16.840.1.113883.10.20.20.3.3)
    2. Entry
      Genetic Disease Assessed Indication Observation (2.16.840.1.113883.10.20.20.3.3.1)
    3. Entry
      Medication Assessed Indication Observation (2.16.840.1.113883.10.20.20.3.3.2)
  3. Section
    Test Performed Section (2.16.840.1.113883.10.20.20.1.10)
    1. Entry
      Test Performed Observation (2.16.840.1.113883.10.20.20.3.4)
  4. Section
    Findings Section (2.16.840.1.113883.10.20.20.1.12)
  5. Section
    Interpretation Section (2.16.840.1.113883.10.20.20.1.13)
    1. Entry
      Interpretive Phenotype (2.16.840.1.113883.10.20.20.2.5)
  6. Section
    Test Information Section (2.16.840.1.113883.10.20.20.1.9)
    1. Section
      Background Section (2.16.840.1.113883.10.20.20.1.9.1)
    2. Section
      Methodology Section (2.16.840.1.113883.10.20.20.1.9.2)
    3. Section
      References Section (2.16.840.1.113883.10.20.20.1.9.3)
  7. Section
    Specimen Section (2.16.840.1.113883.10.20.20.1.7)
    1. Entry
      Genomic Source Class (2.16.840.1.113883.10.20.20.3.2)
17. Section
  Test Information Section (2.16.840.1.113883.10.20.20.1.9)
  1. Section
    Background Section (2.16.840.1.113883.10.20.20.1.9.1)
  2. Section
    Methodology Section (2.16.840.1.113883.10.20.20.1.9.2)
  3. Section
    References Section (2.16.840.1.113883.10.20.20.1.9.3)